Skip to main content
. 2011 Aug 3;23(3):313–319. doi: 10.1007/s00192-011-1532-y

Table 2.

Characteristics and disorders of POP and control index cases and their first and second degree family members

Index cases POP total n (%) or median [range] Control total n (%) or median [range] p value
Age [years] 110 63 [51–89] 100 64 [51–95] 0.37
Children [number] 110 2 [1–11] 100 3 [1–10] 0.03
BMI [kg/m2] 84 25 [17–41] 90 25 [19–42] 0.33
Smokinga 65 21 (32) 83 38 (46) 0.02
Menopauseb 93 89 (96) 94 89 (95) 0.14
Pulmonary diseasec 54 7 (13) 84 9 (11) 0.09
Collagen-associated disordersd
- AAA 59 0 (0) 84 1 (1) 1.00
- Inguinal hernia 55 0 (0) 84 0 (0) 1.00
- Cardiac valve prolapse 58 0 (0) 84 2 (2) 0.51
- Varicose veins 55 15 (27) 84 5 (6) <0.01
- Intervertebral disc displacement 53 5 (9) 84 8 (10) 1.00
- Umbilical hernia 53 3 (6) 84 2 (2) 0.38
- Joint hypermobility 63 12 (19) 82 2 (2) <0.01
- Rectal prolapse 53 13 (25) 84 0 (0) <0.01
Presence of collagen-associated disorderb 63 31(49) 84 18(21) <0.01
Fascia wound dehiscence 53 2 (4) 84 1 (1) 0.56
Diaphragmatic hernia 52 1 (2) 84 1 (1) 1.00
First and second degree family members
 Prolapse
- Mother 110 77 (70) 100 20 (20) <0.01
- Sisters 231 78 (34) 166 6 (4) <0.01
 Collagen-associated disordersd
- AAA 59 1 (2) 84 1 (1) 1.00
- Inguinal hernia 55 7 (13) 84 1 (1) 0.62
- Cardiac valve prolapse 58 0 (0) 84 2 (2) 0.23
- Varicose veins 55 5 (9) 84 8 (10) 0.53
- Intervertebral disc displacement 53 9 (17) 84 8 (10) 0.78
- Umbilical hernia 53 0 (0) 84 1 (1) 0.48
- Joint hypermobility 63 0 (0) 82 2 (2) 0.23
- Rectal prolapse 53 0 (0) 84 0 (0) 1.00
Presence of collagen-associated disordere 63 12 (19) 84 12 (14) 0.82
Fascia wound dehiscence 53 0 (0) 84 0 (0) 1.00
Diaphragmatic hernia 52 1 (2) 84 2 (2) 0.61

p value for difference between POP and control groups using Fisher’s Exact test except for patient characteristics for which Kruskal–Wallis test was used

POP pelvic organ prolapse, BMI body mass index, AAA abdominal aorta aneurysm

aIncluding former smokers

bIncluding post-menopausal women using hormone replacement therapy

cIncluding asthma, chronic obstructive pulmonary disease, bronchitis and other pulmonary diseases

dMultiple diagnoses per person possible

eAt least one of the collagen-associated disorders mentioned above